Medinice has an investment agreement to acquire 1.2 million series M shares at a price of 8 PLN per share

According to the provisions of the investment agreement, the Parmanand Family Foundation has committed to subscribe for and pay for 1,200,000 series M shares of Medinice in exchange for a total issue price of PLN 9,600,000, i.e., at an issue price of PLN 8 per share.

In a subsequent announcement, Medinice stated that it had received an offer from the Parmanad Family Foundation, based in Warsaw, to subscribe for newly issued Series M shares of the company for a total amount of PLN 9,600,000, at an issue price not lower than PLN 8 per share.

At the end of September 2024, Medinice announced the convening of an extraordinary general meeting of shareholders on October 25 to discuss a potential private issuance of up to 1.2 million Series M shares. The purpose of the issuance is to raise capital for completing the certification and commercialization of the company’s leading projects, which are in an advanced stage of clinical trials.